Listen to MS News Today’s Exclusive Interview With Roche on Ocrelizumab

Isaura Santos avatar

by Isaura Santos |

Share this article:

Share article via email

Dr. Peter Chin, a renowned neurologist and Principal Medical Director of Global Neuroscience Development at Genentech, a member of the Roche Group, participated in an exclusive interview with Multiple Sclerosis News Today correspondent Dr. Ana de Barros on the company’s promising multiple sclerosis (MS) therapy ocrelizumab.

Read the article:

The Multiple Sclerosis Podcast